Raloxifene | compare suppliers & send inquiries for free

Here you will find a list of producers, manufacturers and traders of Raloxifene. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.

		GMP	CEP	WC	FDA	DMF	Available for download Document available for download after approval of supplier Set as available by supplier but document not uploaded yet
Torrent Pharma Type: Producer Produced in: India	Producer	−	−	−	−		+ 0	Send inquiry Replies slower than most
Cadila Pharma Type: Producer Produced in: India	Producer		−		−		+ 0	Send inquiry Replies slower than most
Apotex Pharmachem Type: Producer Produced in: India	Producer				−		+ 0	Send inquiry Replies slower than most
omicron pharma Type: Producer Produced in: India	Producer		−	−	−	−	+ 2	Send inquiry Replies quickly
Aarti Drugs Type: Producer Produced in: India	Producer		−		−		+ 0	Send inquiry Replies slower than most
Cambrex Type: Producer Produced in: Italy	Producer	−	−	−	−		+ 1	Send inquiry Replies slower than most
Hanmi Fine Chemical Type: Producer Produced in: South Korea	Producer	−	−	−	−	−	+ 1	Send inquiry Replies slower than most
Sai-Tech Pharmaceuticals Pvt. Ltd. Type: Producer Produced in: India	Producer	−	−	−	−	−	+ 0	Send inquiry Replies slower than most
Glochem Type: Producer Produced in: India	Producer					−	+ 0	Send inquiry Replies slower than most
Raks Pharma Type: Producer Produced in: India	Producer	−	−	−	−		+ 0	Send inquiry Replies slower than most
Aurobindo Type: Producer Produced in: India	Producer	−			−		+ 0	Send inquiry Not active
Erregierre Type: Producer Produced in: Italy	Producer			−			+ 1	Send inquiry Not active
Hetero Drugs Type: Producer Produced in: India	Producer						+ 0	Send inquiry Not active
Dr. Reddy's Type: Producer Produced in: India	Producer	−			−		+ 0	Send inquiry Not active
Cipla Type: Producer Produced in: India	Producer	−	−	−	−		+ 0	Send inquiry Not active
Teva API Type: Producer Produced in: Israel	Producer	−	−	−	−		+ 0	Send inquiry Not active
Olon Type: Producer Produced in: Italy	Producer	−		−	−		+ 0	Send inquiry Not active

Looking for Raloxifene 84449-90-1?

API | Excipient name:: Raloxifene
Synonyms:: Keoxifene, LY 139481, RAL, Raloxifene, Raloxifeno, Raloxifenum, Raloxifene hydrochloride
Cas Number:: 84449-90-1
DrugBank number:: DB00481
Unique Ingredient Identifier:: YX9162EO3I

About Raloxifene

What makes Raloxifene unique? Raloxifene is a second generation selective estrogen receptor modulator (SERM) that mediates anti-estrogenic effects on breast and uterine tissues, and estrogenic effects on bone, lipid metabolism, and blood coagulation Exhibiting tissue-specific effects distinct from estradiol, raloxifene is the first of the benzothiophene group of antiestrogens to be labelled a SERM. Available in many countries worldwide, raloxifene was initially approved by the FDA in December, 1997 under the market name Evista® for the management and prevention of osteoporosis in postmenopausal women and reduction in risk for invasive breast cancer in postmenopausal women with osteoporosis or those who are at high risk for invasive breast cancer. However, it has a negligible effect on altering the development and progression of breast cancer itself. The most common causes of osteoporosis include postmenopausal deficiency of estrogen and age-related deterioration in bone homeostasis.

Due to the risk of bone fractures that may lead to morbidities and reduced quality of life, the management of osteoporosis in postmenopausal women with the use of therapeutic agents in addition to concurrent therapies is critical. Due to the decline in estrogen levels in postmenopausal osteoporosis, hormone replacement therapy (HRT), such as estradiol, has been used to ameliorate the condition. However, due to the off-target actions by HRT, newer non-hormonal agents such as raloxifene and tamoxifen have been developed to reduce adverse events through selective pharmacological actions on tissue-specific therapeutic targets. The main effects of raloxifene are to preserve the bone mineral density and decrease the risk of breast cancer in postmenopausal women. Compared to estrogen and tamoxifen, raloxifene was not associated with an increased risk of uterine cancer and it does not cause endometrial proliferation.

You can ask the supplier about all relevant certificates for the product such as CoA, Safety Data Sheet and DMF.

Raloxifene manufacturers | traders | suppliers
We have 17 companies offering Raloxifene from 4 different countries.

Get in contact with the supplier of your choice:

Hetero Drugs from India
omicron pharma from India
Aarti Drugs from India
Erregierre from Italy
Aurobindo from India
Apotex Pharmachem from India
Dr. Reddy's from India
Cadila Pharma from India
Olon from Italy
Teva API from Israel
Torrent Pharma from India
Glochem from India
Cambrex from Italy
Cipla from India
Raks Pharma from India
Hanmi Fine Chemical from South Korea
Sai-Tech Pharmaceuticals Pvt. Ltd. from India

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.